echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Differential diagnosis of liver T2 hyperintensity center scar lesions

    Differential diagnosis of liver T2 hyperintensity center scar lesions

    • Last Update: 2021-11-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Differential diagnosis : T2 hyperintensity center scar


    Differential diagnosis : T2 hyperintensity center scar diagnosis


    Differential Diagnosis: T2 Bright Central Scar Differential Diagnosis: T2 Bright Central Scar

    ① T2 hyperintensity and higher signal central scar, peripheral nodular enhancement, continuous and progressive enhancement

    ① ① T2 hyperintensity and higher signal central scar, peripheral nodular enhancement, continuous and progressive enhancement
    • T2 bright lesion

    • T2 brighter scar

    • Peripheral nodular enhancement

    • Persistent enhancement

  • T2 bright lesion

  • T2 bright lesion

    T2 bright lesion
  • T2 brighter scar

  • T2 brighter scar

    T2 brighter scar
  • Peripheral nodular enhancement

  • Peripheral nodular enhancement

    Peripheral nodular enhancement
  • Persistent enhancement

  • Persistent enhancement

    Persistent enhancement

     

     

     

    Huge and medium-sized blood vessels tumors 

    Huge and medium-sized blood vessels tumorshuge and medium-sized blood vessels of tumorblood vessels

    Giant and a mid-size hemangioma

    Giant and a mid-size hemangioma Giant and a mid-size hemangioma

    ② T2 and other signals with slightly higher signal scars, obviously and evenly enhanced, cleared to equal signals

    ② ② T2 and other signals with slightly higher signal scars, obviously and evenly enhanced, cleared to equal signals
    • T2 isointense

    • T2 slightly brighter scar

    • Homogeneous enhancement

    • fades to isointensity

  • T2 isointense

  • T2 isointense

    T2 isointense
  • T2 slightly brighter scar

  • T2 slightly brighter scar

    T2 slightly brighter scar
  • Homogeneous enhancement

  • Homogeneous enhancement

    Homogeneous enhancement
  • fades to isointensity

  • fades to isointensity

    fades to isointensity

     

     

     

    Focal nodular hyperplasia (FNH)

    Focal Nodular Hyperplasia (FNH) Focal Nodular Hyperplasia (FNH)

    Focal nodular hyperplasia

    Focal nodular hyperplasia Focal nodular hyperplasia

    ③ T2 mild hyperintensity and higher intensity scar, heterogeneous enhancement, clearance and capsule enhancement

    ③ ③ T2 mild hyperintensity and higher intensity scar, heterogeneous enhancement, clearance and capsule enhancement
    • T2 slightly bright lesion

    • T2 brighter scar

    • Heterogeneous enhancement

    • Washout with capsular enhancement

  • T2 slightly bright lesion

  • T2 slightly bright lesion

    T2 slightly bright lesion
  • T2 brighter scar

  • T2 brighter scar

    T2 brighter scar
  • Heterogeneous enhancement

  • Heterogeneous enhancement

    Heterogeneous enhancement
  • Washout with capsular enhancement

  • Washout with capsular enhancement

    Washout with capsular enhancement

     

     

     

    Hepatocellular carcinoma (massive type)


    Hepatocellular carcinoma (massive type)


    Hepatocellular carcinoma Hepatocellular carcinoma

    summary

    Summary summary
    • Evaluation on T2WI: the first case, hyperintensity lesion + higher intensity scar


    • Evaluation of the enhanced arterial phase: the first case, peripheral nodular enhancement


    • Assessment of enhanced portal phase: the first case, concentric progressive enhancement


    • Assess the enhancement delay period: the first case, continuous enhancement and no enhancement of the central scar


  • Evaluation on T2WI: the first case, hyperintensity lesion + higher intensity scar


  • Evaluation on T2WI: the first case, hyperintensity lesion + higher intensity scar


    Evaluation on T2WI: the first case, hyperintensity lesion + higher intensity scar


    Evaluation of the enhanced arterial phase: the first case, peripheral nodular enhancement


    Evaluation of the enhanced arterial phase: the first case, peripheral nodular enhancement


    Assessment of enhanced portal phase: the first case, concentric progressive enhancement


    Assessment of enhanced portal phase: the first case, concentric progressive enhancement


    Assess the enhancement delay period: the first case, continuous enhancement and no enhancement of the central scar


    Assess the enhancement delay period: the first case, continuous enhancement and no enhancement of the central scar
    .
    In the second case, isosignal and central scar and separation enhancement
    .
    The third case was clarification and enhancement of false capsule
    .

     

     

    ☆  Content source: English book "Liver MRI"

    ☆  Content source: English book "Liver MRI" ☆  Content source: English book "Liver MRI"

    Supplementary case and explanation 

    Supplementary case and explanation 

    Hepatocellular carcinoma , the main characteristics: enhanced scan "fast in and out", central fissure necrosis, obvious limited diffusion, false capsule
    .

    Hepatocellular carcinoma .
    The main characteristics of hepatocellular carcinoma are: enhanced scan "fast in and out", central fissure necrosis, obvious limited diffusion, and false capsule
    .

    FNH , the main features: T2WI or other slightly higher signal, higher signal scar in the center, obvious tumor enhancement in the arterial phase, or slightly higher signal in the delayed phase, and iso-signal in the hepatobiliary phase
    .

    FNH , the main features: T2WI or other slightly higher signal, higher signal scar in the center, obvious tumor enhancement in the arterial phase, or slightly higher signal in the delayed phase, and iso-signal in the hepatobiliary phase
    .

    Liver metastases (liver puncture: small cell carcinoma; left lower lung occupancy was also found) , the main characteristics: small round shape, clear border, limited diffusion, lack of blood supply, delayed central enhancement
    .

    Liver metastases (liver puncture: small cell carcinoma; another found left lower lung space) Liver metastases (liver puncture: small cell carcinoma; another left lower lung space occupied) , main features: small round shape, clear border, diffuse Limitation, lack of blood supply, and central enhancement in the delayed phase
    .
    Liver lesions with central scars Liver lesions with central scars

    Part of the data source: Differential diagnosis of imaging experts-Abdominal part booklet



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.